JPMorgan Chase & Co’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.82M Buy
415,989
+117,439
+39% +$1.64M ﹤0.01% 2587
2025
Q1
$4.02M Sell
298,550
-5,784
-2% -$78K ﹤0.01% 2813
2024
Q4
$5.83M Sell
304,334
-96,017
-24% -$1.84M ﹤0.01% 2639
2024
Q3
$9.11M Buy
400,351
+274,641
+218% +$6.25M ﹤0.01% 2220
2024
Q2
$1.64M Buy
125,710
+76,687
+156% +$998K ﹤0.01% 3234
2024
Q1
$858K Sell
49,023
-7,915
-14% -$139K ﹤0.01% 3666
2023
Q4
$1.24M Buy
56,938
+6,016
+12% +$131K ﹤0.01% 3411
2023
Q3
$781K Sell
50,922
-9,050
-15% -$139K ﹤0.01% 3533
2023
Q2
$1.43M Buy
59,972
+10,595
+21% +$252K ﹤0.01% 3222
2023
Q1
$1.26M Sell
49,377
-122,982
-71% -$3.13M ﹤0.01% 3303
2022
Q4
$5.03M Buy
172,359
+103,101
+149% +$3.01M ﹤0.01% 2367
2022
Q3
$1.42M Buy
69,258
+50,919
+278% +$1.04M ﹤0.01% 3142
2022
Q2
$213K Sell
18,339
-327
-2% -$3.8K ﹤0.01% 4296
2022
Q1
$345K Buy
18,666
+5,633
+43% +$104K ﹤0.01% 4187
2021
Q4
$258K Buy
+13,033
New +$258K ﹤0.01% 4408
2021
Q2
Sell
-10
Closed 5658
2021
Q1
$0 Buy
+10
New ﹤0.01% 5394
2020
Q4
Sell
-21,290
Closed -$255K 5114
2020
Q3
$255K Hold
21,290
﹤0.01% 3641
2020
Q2
$354K Hold
21,290
﹤0.01% 3433
2020
Q1
$142K Hold
21,290
﹤0.01% 3833
2019
Q4
$153K Hold
21,290
﹤0.01% 3906
2019
Q3
$233K Sell
21,290
-2,660
-11% -$29.1K ﹤0.01% 3684
2019
Q2
$794K Buy
23,950
+2,238
+10% +$74.2K ﹤0.01% 3161
2019
Q1
$909K Sell
21,712
-4,429
-17% -$185K ﹤0.01% 3075
2018
Q4
$1.19M Buy
26,141
+1,944
+8% +$88.3K ﹤0.01% 2938
2018
Q3
$2.03M Buy
24,197
+476
+2% +$39.9K ﹤0.01% 2780
2018
Q2
$2.28M Buy
23,721
+1,881
+9% +$181K ﹤0.01% 2730
2018
Q1
$2.3M Sell
21,840
-63
-0.3% -$6.63K ﹤0.01% 2664
2017
Q4
$3.43M Buy
21,903
+613
+3% +$95.9K ﹤0.01% 2477
2017
Q3
$2.82M Buy
+21,290
New +$2.82M ﹤0.01% 2480